Introduction
The clinical outcome of Ep stein-Barr virus (EBV) infections is determined by the viral activity and by the host's cellular immune response. In immunocompetent individuals normall y selflimiting infectious mononucleosis (1M) occurs after primary E BV infection, but patients with inherited or acquired immunodeficiencies such as, e. g., X-linked lymphoproliferative syndrome (XLP, also known as Duncan's di sease), human immunodeficiency virus type-l (HIV-l) disease or immunosuppressive therapy. ma y develop life-threatening E BV -associated lymphoproliferative disorders and lymphomas (1).
Neopterin concentrations in body fluid s a re a means for assessing early steps of activation of cellular immunity because neopterin is produced in large amounts by human macrophages after stimulation with interferon gamma (2).
In order to learn more about the activation state of cell-mediated immunity in EBV-related lymphoproliferative disorders, we determined serum concentrations ofneopterin and of interferon gamma in patients with active and chronic EBV infection s and in two with EBV -associated epithelial tumors.
2) To whom correspondence sho uld be addressed . Table 1 .
Neopterin was determined simultaneously with creatinine by a high performance liquid chromatography method involving solid-phase extraction of the small molecular mass components, followed by on-line elution onto a n analytical column packed with reversedphase C18 material and fluorescence detection of native neopterin (without oxidative pretreatment) (3) . Normal values of neopterin in serum were determined earlier in 263 healthy children , aged from 1 to 18 years (5th percentile, 3.5 nmol/liter; median, 6.0 nmol / liter; 95th percentile, 13.5 nmol /liter), and in 359 healthy adults, aged from 19 to 75 years (2.6; 4.9; 8.7)
Interferon gamma was measured using a modified immunoradiometric procedure suited for detection of the low concentrations typically found in human serum (4) . Using this assay for IFN gamma on samples from health y blood donors, we have previously fo und 100 U /liter as 95th percentile (5), and this value was chosen as upper limit of normal range. As noted, serum creatinine was concomitantly determined; there were no abnormal values detected in the studied specimens (median value was 56 Ilmol/liter with a range from 24.0 to 76.4). 
Results and Discussion
The patient exhibiting the highest concentrations of both neopterin and IFN gamma ( Two adults with EBV-associated epithelial tumors showed normal values of neopterin and IFN-gamma. Both patients were in complete remission, although antibodies to EBV EA were positive. These data are in accord with previous studies showing normal neopterin concentrations in urine of patients with malignant tumors in remission (2).
We conclude from this pilot study that measurement of neopterin in serum of patients with EBV -associated diseases provides a sensitive insight into the activation state of early cell-mediated immune reactions: like other viral diseases active infectious mononucleosis is regularly associated with raised concentrations of neopterin, but highest (and probably persistently raised) values seem to indicate poorer prognosis like in other diseases. Ultimately, neopterin determination might influence therapeutic decisions: immunostimulatory therapy with IFNs may be more useful in patients with low endogenous IFN gamma production being sensitively indicated by low neopterin (9, 10).
